CLPTM1L and ovarian cystadenocarcinoma: Spheroid growth was also inhibited in a dose-dependent manner by 102-5 anti-CLPTM1L in cisplatin-resistant, stem-like cell lines HeyA8-CisR, OVCAR5-CisR (HGSOC), and PeO4 (ovarian cystadenocarcinoma) (Supplementary Fig. 2).